CMS(00867),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

00867 CMS

Noon Closed 01-22 12:05:00

13.620

-0.100

-0.73%

High13.880	Low13.440	Vol911.00K
Open13.700	D1 Closing13.720	Amplitude3.21%
Mkt Cap33.23B	Tradable Cap33.23B	Total Shares2.44B
T/O12.44M	T/O Rate0.04%	Tradable Shares2.44B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"00867","market":"HK","secType":"STK","nameCN":"CMS","latestPrice":13.62,"timestamp":1769054700002,"preClose":13.72,"halted":0,"volume":911000,"delay":0,"changeRate":-0.007288629737609432,"floatShares":2439528512,"shares":2440000000,"eps":0.667298,"marketStatus":"Noon Closed","change":-0.1,"latestTime":"01-22 12:05:00","open":13.7,"high":13.88,"low":13.44,"amount":12440750,"amplitude":0.03207,"askPrice":13.66,"askSize":4000,"bidPrice":13.62,"bidSize":2000,"shortable":3,"etf":0,"ttmEps":0.748149,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1769058000000},"marketStatusCode":3,"adr":0,"listingDate":1285603200000,"exchange":"SEHK","adjPreClose":13.72,"dividendRate":0.022421,"openAndCloseTimeList":[[1769045400000,1769054400000],[1769058000000,1769068800000]],"volumeRatio":0.71103,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/00867/tweets","defaultTab":"tweets","newsList":[{"id":"1128251180","title":"CMS Securities Initiates Coverage on CMS (00867) with \"Strongly Recommend\" Rating, Citing Innovation and Internationalization Driving Commercial Leader into New Phase","url":"https://stock-news.laohu8.com/highlight/detail?id=1128251180","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128251180?lang=en_us&edition=fundamental","pubTime":"2026-01-21 09:48","pubTimestamp":1768960118,"startTime":"0","endTime":"0","summary":"CMS Securities released a research report initiating coverage on CMS (00867) with a \"Strongly Recommend\" rating. The institution believes the impact of centralized drug procurement on the company's...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2488822045.USD","SG9999015986.USD","SG9999015952.SGD","00867","IE00BYV24P56.USD","IE00BVYPNQ40.USD","IE00BVYPNP33.GBP","BK1191","SG9999004220.SGD","SG9999015945.SGD","SG9999015978.USD","IE00BMCWC346.EUR","BK1147","BK1593","06099","IE00BGHQDM52.EUR","BK1564"],"gpt_icon":0},{"id":"2601685334","title":"An Insider At China Medical System Holdings Lowered Their Holding Recently","url":"https://stock-news.laohu8.com/highlight/detail?id=2601685334","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601685334?lang=en_us&edition=fundamental","pubTime":"2026-01-08 07:10","pubTimestamp":1767827456,"startTime":"0","endTime":"0","summary":"Viewing insider transactions for China Medical System Holdings Limited's ( HKG:867 ) over the last year, we see that...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-867/china-medical-system-holdings-shares/news/an-insider-at-china-medical-system-holdings-lowered-their-ho","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-867/china-medical-system-holdings-shares/news/an-insider-at-china-medical-system-holdings-lowered-their-ho","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IE00BVYPNQ40.USD","IE00BVYPNP33.GBP","IE00BYV24P56.USD","IE00BMCWC346.EUR","SG9999015978.USD","00867","LU2488822045.USD","SG9999004220.SGD","BK1191","BK1593","SG9999015945.SGD","SG9999015952.SGD","SG9999015986.USD","IE00BGHQDM52.EUR"],"gpt_icon":0},{"id":"2592891022","title":"China Medical System Holdings (SEHK:867): Valuation Check After Y-3 Stroke Drug NDA Acceptance and Phase III Success","url":"https://stock-news.laohu8.com/highlight/detail?id=2592891022","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592891022?lang=en_us&edition=fundamental","pubTime":"2025-12-17 18:34","pubTimestamp":1765967650,"startTime":"0","endTime":"0","summary":"China Medical System Holdings (SEHK:867) just cleared a meaningful hurdle, with regulators accepting its New Drug Application for Y-3 for Injection after a successful Phase III trial in acute ischemic stroke patients.\nSee our latest analysis for China Medical System Holdings.\nDespite a softer 30 day share price return and some recent consolidation, China Medical System Holdings still sits at HK$13.40, with strong upward share price return year to date and a robust multi year total shareholder...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-867/china-medical-system-holdings-shares/news/china-medical-system-holdings-sehk867-valuation-check-after","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-867/china-medical-system-holdings-shares/news/china-medical-system-holdings-sehk867-valuation-check-after","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["SG9999015952.SGD","SG9999015986.USD","00867","IE00BMCWC346.EUR","IE00BYV24P56.USD","DCF","BK1191","SG9999015945.SGD","SG9999015978.USD","IE00BGHQDM52.EUR","III","BK4134","BK1593","SG9999004220.SGD","IE00BVYPNP33.GBP","LU2488822045.USD","IE00BVYPNQ40.USD"],"gpt_icon":0},{"id":"1164514638","title":"Guoyuan International Initiates \"Buy\" Rating on CMS (00867) with Target Price of HK$17.68","url":"https://stock-news.laohu8.com/highlight/detail?id=1164514638","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164514638?lang=en_us&edition=fundamental","pubTime":"2025-12-17 14:44","pubTimestamp":1765953876,"startTime":"0","endTime":"0","summary":"Guoyuan International released a research report highlighting that CMS (00867) has established a global pipeline of 40 innovative drugs, primarily featuring First-in-Class (FIC) and Best-in-Class...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999015945.SGD","IE00BYV24P56.USD","SG9999015978.USD","BK1593","00867","SG9999015986.USD","IE00BVYPNQ40.USD","SG9999004220.SGD","BK1191","IE00BVYPNP33.GBP","SG9999015952.SGD","IE00BMCWC346.EUR","LU2488822045.USD","IE00BGHQDM52.EUR"],"gpt_icon":0},{"id":"2591641369","title":"Dermavon Secures Breakthrough Drug Status for Oral JAK1 Inhibitor in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2591641369","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591641369?lang=en_us&edition=fundamental","pubTime":"2025-12-15 21:19","pubTimestamp":1765804781,"startTime":"0","endTime":"0","summary":"Dermavon, a China Medical System Holdings Ltd. Subsidiary, Gains Breakthrough Drug Status in China for Oral JAK1 Inhibitor Povorcitinib. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China Medical System Holdings Ltd. published the original content used to generate this news brief via GlobeNewswire  on December 15, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251215:nNDL3jH6N4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2488822045.USD","BK1593","LU2210150020.SGD","00867","IE00BVYPNP33.GBP","LU0314104364.USD","SG9999014005.SGD","SG9999015945.SGD","SG9999014013.SGD","SG9999004220.SGD","SG9999014021.USD","IE00B64PRP62.GBP","IE00BVYPNQ40.USD","BK4585","IE00BGHQDM52.EUR","LU2095319765.USD","SG9999015978.USD","IE00BGHQF748.EUR","BK1191","IE00BKPKM429.USD","SG9999015986.USD","IE00BYV24P56.USD","IE00B3QW5Z07.USD","BK4588","NDAQ","BK4112","IE00BMCWC346.EUR","LU2210149790.SGD","SG9999015952.SGD","SG9999014039.USD"],"gpt_icon":0},{"id":"1107899930","title":"CMS (00867): Innovative Oral JAK1 Inhibitor Povorcitinib Included in Breakthrough Therapy List","url":"https://stock-news.laohu8.com/highlight/detail?id=1107899930","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107899930?lang=en_us&edition=fundamental","pubTime":"2025-12-15 19:54","pubTimestamp":1765799662,"startTime":"0","endTime":"0","summary":"CMS (00867) announced that povorcitinib, an innovative oral JAK1 inhibitor (proposed Chinese generic name: phosphate povorcitinib tablets) with licensing rights held by its subsidiary Demai...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2488822045.USD","SG9999015986.USD","BK1161","159992","00867","IE00BYV24P56.USD","SG9999015952.SGD","IE00BVYPNQ40.USD","BK1574","BK1191","SG9999004220.SGD","SG9999015945.SGD","SG9999015978.USD","IE00BMCWC346.EUR","BK1593","IE00BVYPNP33.GBP","06978","IE00BGHQDM52.EUR"],"gpt_icon":0},{"id":"2591643410","title":"China Medical System's Povorcitinib Listed as Breakthrough Therapeutic Drug by China NMPA","url":"https://stock-news.laohu8.com/highlight/detail?id=2591643410","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591643410?lang=en_us&edition=fundamental","pubTime":"2025-12-15 19:43","pubTimestamp":1765799018,"startTime":"0","endTime":"0","summary":"China Medical System Holdings Ltd. announced that its subsidiary, Dermavon Holdings Limited, has obtained regulatory recognition for its innovative oral JAK1 inhibitor, povorcitinib. The drug has been included in the list of Breakthrough Therapeutic Drugs by the Center for Drug Evaluation of the National Medical Products Administration of China, with a proposed indication for adult patients with non-segmental vitiligo. This designation is expected to accelerate the development and review process of povorcitinib.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China Medical System Holdings Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251215:nNDL55pJRd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999015978.USD","IE00BVYPNQ40.USD","BK1593","LU2488822045.USD","IE00BVYPNP33.GBP","IE00BGHQDM52.EUR","BK1191","IE00BMCWC346.EUR","SG9999004220.SGD","SG9999015952.SGD","SG9999015986.USD","00867","SG9999015945.SGD","IE00BYV24P56.USD"],"gpt_icon":0},{"id":"2591661359","title":"What China Medical System Holdings (SEHK:867)'s Stroke Drug NDA Acceptance Means For Shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2591661359","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591661359?lang=en_us&edition=fundamental","pubTime":"2025-12-14 17:17","pubTimestamp":1765703856,"startTime":"0","endTime":"0","summary":"On 11 December 2025, China Medical System Holdings announced that China’s National Medical Products Administration accepted the New Drug Application for Y-3 (Loberamisal) for Injection, a Class 1 innovative brain cytoprotectant for acute ischemic stroke based on PSD-95-nNOS and MPO targets.\nThis first-in-class, multi-target therapy addresses both stroke damage and post-stroke mood complications, positioning the company more firmly in China’s large and complex cerebrovascular disease...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-867/china-medical-system-holdings-shares/news/what-china-medical-system-holdings-sehk867s-stroke-drug-nda","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-867/china-medical-system-holdings-shares/news/what-china-medical-system-holdings-sehk867s-stroke-drug-nda","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IE00BVYPNQ40.USD","BK1593","IE00BMCWC346.EUR","IE00BGHQDM52.EUR","SG9999015986.USD","SG9999015952.SGD","SG9999015978.USD","IE00BYV24P56.USD","00867","IE00BVYPNP33.GBP","SG9999004220.SGD","LU2488822045.USD","SG9999015945.SGD","BK1191"],"gpt_icon":0},{"id":"1113555991","title":"CMS (00867): China's NMPA Accepts New Drug Application for Class 1 Innovative Drug Y-3 Injection for Acute Ischemic Stroke","url":"https://stock-news.laohu8.com/highlight/detail?id=1113555991","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113555991?lang=en_us&edition=fundamental","pubTime":"2025-12-11 19:24","pubTimestamp":1765452271,"startTime":"0","endTime":"0","summary":"CMS (00867) announced that the New Drug Application (NDA) for its Class 1 innovative drug Y-3 Injection (proposed Chinese generic name: Lobe Miliu Injection) has been accepted by China's National...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BVYPNP33.GBP","BK1191","IE00BMCWC346.EUR","SG9999015945.SGD","BK1593","LU2488822045.USD","IE00BYV24P56.USD","SG9999004220.SGD","SG9999015986.USD","00867","IE00BVYPNQ40.USD","SG9999015978.USD","IE00BGHQDM52.EUR","SG9999015952.SGD"],"gpt_icon":0},{"id":"2590059704","title":"China Medical System -  Nda of Class 1 Innovative Drug Y-3 for Injection Accepted by China's Nmpa","url":"https://stock-news.laohu8.com/highlight/detail?id=2590059704","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590059704?lang=en_us&edition=fundamental","pubTime":"2025-12-11 19:17","pubTimestamp":1765451876,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251211:nFWN3XH0KL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SG9999015952.SGD","IE00BYV24P56.USD","SG9999015986.USD","BK1593","IE00BVYPNQ40.USD","IE00BVYPNP33.GBP","LU2488822045.USD","BK1191","SG9999015978.USD","IE00BMCWC346.EUR","IE00BGHQDM52.EUR","SG9999004220.SGD","SG9999015945.SGD","00867"],"gpt_icon":0},{"id":"2590559702","title":"China Medical System's New Drug Application for Y-3 Injection Accepted in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2590559702","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590559702?lang=en_us&edition=fundamental","pubTime":"2025-12-11 19:17","pubTimestamp":1765451844,"startTime":"0","endTime":"0","summary":"China Medical System Holdings Ltd. announced that the New Drug Application  for its Class 1 Innovative Drug Y-3 for Injection, intended for the treatment of acute ischemic stroke, has been accepted for review in China. The company entered into a collaboration agreement with Neurodawn Pharmaceutical Co., Ltd., granting China Medical System exclusive promotion rights for the product in mainland China, Hong Kong, and Macau. The acceptance of the NDA marks a significant regulatory milestone and is expected to positively impact the company's innovative drug portfolio in the central nervous system field.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China Medical System Holdings Ltd. published the original content used to generate this news","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251211:nNDLyTdth:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BVYPNQ40.USD","BK1191","SG9999015945.SGD","SG9999015986.USD","IE00BMCWC346.EUR","SG9999004220.SGD","00867","SG9999015952.SGD","IE00BVYPNP33.GBP","BK1593","LU2488822045.USD","IE00BGHQDM52.EUR","SG9999015978.USD","IE00BYV24P56.USD"],"gpt_icon":0},{"id":"2590337617","title":"China Medical System Holdings (HKG:867) Could Easily Take On More Debt","url":"https://stock-news.laohu8.com/highlight/detail?id=2590337617","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590337617?lang=en_us&edition=fundamental","pubTime":"2025-12-10 06:37","pubTimestamp":1765319836,"startTime":"0","endTime":"0","summary":"Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-867/china-medical-system-holdings-shares/news/china-medical-system-holdings-hkg867-could-easily-take-on-mo-4","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-867/china-medical-system-holdings-shares/news/china-medical-system-holdings-hkg867-could-easily-take-on-mo-4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["00867","SG9999004220.SGD","BK1593","IE00BVYPNP33.GBP","IE00BYV24P56.USD","SG9999015978.USD","SG9999015945.SGD","IE00BMCWC346.EUR","IE00BGHQDM52.EUR","EBIT","IE00BVYPNQ40.USD","SG9999015986.USD","LU2488822045.USD","BK1191","SG9999015952.SGD"],"gpt_icon":0},{"id":"1134728285","title":"10th Zhitong Capital Market Annual Conference Honors Excellence with 25 Awards Unveiled","url":"https://stock-news.laohu8.com/highlight/detail?id=1134728285","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134728285?lang=en_us&edition=fundamental","pubTime":"2025-12-03 19:38","pubTimestamp":1764761917,"startTime":"0","endTime":"0","summary":"On December 3, 2025, the \"10th Zhitong Capital Market Annual Conference & Listed Companies Awards Ceremony,\" jointly hosted by leading Hong Kong and U.S. stock information platform Zhitong Finance...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1719994722.HKD","LU1974910355.USD","IE00BQXX3F31.USD","LU2328871848.SGD","LU2249611893.SGD","LU0431992006.USD","BK1225","LU0488056044.USD","BK1137","02509","BK1096","BK1522","LU0499858602.USD","BK1229","00875","00960","09890","LU0164872284.USD","LU0261950470.USD","LU0072462343.USD","00020","LU0082770016.USD","02276","82020","BK1586","00826","01164","LU0231483743.USD","01907","00136","09639","02382","LU1861214812.USD","BK1221","02556","06100","09985","IE0009570106.USD","LU0588546209.SGD","02298","LU1951186391.HKD","LU2153591404.USD","LU2097828631.EUR","80992","09990","IE00BGHQDM52.EUR","LU0052756011.USD","LU0320764599.SGD","03800","LU0274383008.USD","LU0348735423.USD","LU0819123356.HKD","LU1813983027.USD","LU2242644610.SGD","BK1207","LU1115378108.SGD","BK1518","HK0000306685.HKD","LU1008478684.HKD","LU0269904917.USD","01119","00777","BK1142","BK1574","BK1168","LU2460026573.USD","BK1604","BK1596","00656","IE00BVYPNQ40.USD","LU0348767384.USD","BK1247","LU0214875030.USD","BK1564","LU0516423174.USD","BK1540","BK1595","01600","09860","BK1169","02331","LU0329678170.USD","SG9999015945.SGD","LU1770036033.HKD","02020","BK1515","HK0000306701.USD","IE00B0JY6N72.USD","IE00B29SXG58.USD","LU0359201612.USD","BK1148","02696","LU1981816686.USD","00666","02157","02190","LU0588545904.SGD","02533","LU0384037296.USD","BK1209","02565","02197","02506","IE0031814852.USD","LU1770034418.SGD","LU0054237671.USD","03681","BK1530","02453","HK0000252160.HKD","IE0008369823.USD","IE0032431581.USD","BK1125","BK1528","LU0828237510.HKD","LU0708995583.HKD","01530","09699","LU0229945570.USD","02121","00798","09911","LU1039395188.USD","01405","IE00B8HQ1Z84.USD","00460","LU0348827113.USD","02250","01939","LU0640798160.USD","02431","LU0211977185.USD","LU1868837722.USD","BK1618","LU1917777945.USD","LU0140636845.USD","LU0979878070.USD","00451","LU0417516571.SGD","LU0823426308.USD","LU1282649067.USD","06862","LU0572940350.SGD","LU0856984785.SGD","SG9999015952.SGD","BK1109","LU2008162690.USD","BK1524","BK1195","02392","BK1598","06618","02315","09923","00305","09956","LU0762540952.USD","LU0417516738.SGD","02590","BK1593","LU0456827905.SGD","LU0499858438.USD","LU0329678337.USD","06138","SG9999004220.SGD","09996","01520","LU2476274308.USD","BK1258","06186","LU0620787316.HKD","BK1516","02158","BK1154","LU2399975544.HKD","LU0593848301.USD","LU1046422090.SGD","01952","03680","BK1559","LU0314109678.HKD","01384","LU0326950275.SGD","BK1526","06919","BK1216","BK1188","BK1237","LU0165289439.USD","BK1155","BK1575","BK1609","HK0000252152.HKD","LU0469268626.HKD","BK1600","LU0737861699.HKD","LU0516422952.EUR","BK1550","01640","IE00BGV7N243.SGD","LU1497733631.SGD","LU0588545490.SGD","LU0650527681.SGD","LU0594300179.USD","LU1366334651.USD","00300","BK1544","LU1048588211.SGD","02889","00363","LU0264606111.USD","LU1282649810.SGD","81211","01117","01911","BK1552","BK1215","02273","BYDDY","00855","BK1591","IE00B031J352.USD","IE0003795394.USD","02469","LU0052750758.USD","09926","LU1808992512.USD","BK1224","00884","SGXZ86797644.SGD","LU0289960550.SGD","LU1102505929.USD","BK1253","LU1956131251.USD","LU0345775950.USD","SGXZ90724238.SGD","BK1193","LU0289961442.SGD","LU1634259557.SGD","01833","BK1605","06058","LU0164880469.USD","LU0251143458.SGD","BK1212","BK1583","BK1235","LU0456846285.SGD","IE0003851619.USD","LU0634319403.HKD","LU0702159699.USD","01809","IE00B031HY20.USD","02616","LU1226287792.SGD","00867","LU0048575426.USD","LU0588545730.USD","02171","BK1171","SG9999001226.SGD","BK1579","02380","LU2424517915.HKD","06855","09878","LU0880133367.SGD","01318","01458","BK1548","LU1497734951.SGD","LU2023250504.SGD","LU1807302812.USD","SG9999002463.SGD","BK1186","HYDD.SI","BK1606","LU1226288170.HKD","02650","06086","BK1144","BK1615","01070","BK1230","09877","02436","BK1585","BK1197","02411","IE00BMCWC346.EUR","LU1497733557.USD","IE00BYV24P56.USD","01877","06160","LU0039217434.USD","BK1594","IE00B5MMRT66.SGD","LU2663582299.SGD","06060","86618","03836","BK1095","03709","02419","BK1527","80020","LU2778985437.USD","BK1150","SG9999000475.SGD","LU3063872942.SGD","02018","01773","SG9999002828.SGD","BK1571","ANPDY","LU0043850808.USD","LU0048580855.USD","BK1587","LU0572939691.SGD","BK1175","LU0315178854.USD","LU0327786744.USD","01818","09690","BK1119","LU0348784397.USD","LU2125910500.SGD","SG9999006597.SGD","LU1188198961.HKD","HK0000320264.USD","02420","BK1200","SG9999001069.SGD","LU0251144936.SGD","02057","BK1131","BK1577","LU0505663152.USD","09660","LU2506952253.HKD","BK1519","LU0359201885.HKD","06913","LU1328615791.USD","BK1164","LU0516423091.SGD","LU1831875114.USD","LU1861219969.SGD","LU0348783233.USD","01276","02145","01519","LU0501845795.SGD","BK1219","SG9999000418.SGD","LU0516422440.USD","BK1523","00384","BK1126","BK1582","LU1794554557.SGD","LU2238339852.HKD","06996","LU0261947096.USD","02268","02595","BK1170","BK1589","BK1222","LU0828238088.HKD","02460","03896","LU1868837565.USD","BK1183","BK1239","00302","BK1228","03939","SG9999015978.USD","01762","LU1023057109.AUD","BK1610","02627","BK1560","LU2360107325.USD","02670","LU2153592121.USD","06613","LU1235295612.USD","BK1557","00003","BK1194","82331","01211","LU0011963245.USD","BK1549","BK1114","LU0516422366.SGD","LU1481107354.HKD","LU2294711713.HKD","SG9999001051.SGD","01783","BK1214","02488","09961","SG9999011746.SGD","LU0823038988.USD","06657","BK1233","LU0149721374.USD","IE0034224299.USD","LU2097828805.USD","LU0791590937.USD","LU0611395673.USD","SG9999002562.SGD","01739","IE00BZ08YT58.USD","BK1160","HK0000500386.USD","LU0067412154.USD","LU0823397103.USD","LU2543165471.USD","01880","LU0449509016.USD","BK1500","02167","BK1100","LU1226288253.USD","LU0345776255.USD","01440","BK1191","LU1166156734.SGD","02629","09919","LU0054450605.USD","IE00BQXX3C00.GBP","LU1152091168.USD","LU0072913022.USD","09927","LU2348774022.SGD","LU0531970944.HKD","LU1226287875.USD","IE00B0169L03.USD","LU0259732245.USD","BK1158","01471","LU0868486357.SGD","IE00BZ08YR35.GBP","BK1127","06821","BK1124","02498","06609","BK1240","LU1675838814.USD","06963","HK0000320223.HKD","LU2039709279.SGD","BK1257","02525","BK1556","LU1242518857.USD","LU0051755006.USD","LU1720050803.USD","LU0082770016.SGD","LU0511384066.AUD","BK1578","02279","LU2348773727.SGD","LU0048597586.USD","LU2097828557.USD","BK1542","BK1554","LU0819121731.USD","06683","LU0502904849.HKD","02177","BK1184","BK1504","LU0107464264.USD","LU2177674079.SGD","LU1960683339.HKD","00267","01585","09678","BK1136","LU0823039010.USD","BK1147","02886","00699","BK1227","LU0164939612.USD","SG9999001903.USD","00861","BK1178","BK1566","LU1224709979.USD","LU1993786604.SGD","00382","SG9999003461.SGD","00135","06677","01969","LU1242518931.SGD","BK1521","LU2045819591.USD","09955","LU2506951792.HKD","02551","LU1880383440.USD","LU0164865239.USD","LU1634259391.SGD","LU0531971595.HKD","LU0254981946.USD","LU0463099449.HKD","02105","SGXZ62798434.SGD","LU1522347837.USD","IE00BPRC5H50.USD","LU1211504680.USD","BK1132","IE00BVYPNP33.GBP","LU1303224171.USD","02155","BK1116","LU0871576103.HKD","SG9999001093.SGD","00512","BK1608","BK1220","BK1539","LU1226287529.USD","02100","BK1613","LU1868838027.USD","03145","02142","LU0831093199.SGD","BK1140","LU0315179316.USD","BK1134","LU0244354667.USD","00992","BK1509","02228","BK1198","01378","01735","02096","LU2298064838.USD","01093","LU2476274720.SGD","LU1880383366.USD","IE00B543WZ88.USD","LU0348766576.USD","BK1520","BK1590","LU0572944931.SGD","BK1151","LU0541502299.USD","LU0287142896.SGD","LU0543330566.HKD","BK1555","BK1104","002594","LU1267930227.SGD","BK1597","BK1139","BK1167","LU0049112450.USD","03658","IE00BQXX3D17.EUR","02150","IE00BZ08YS42.EUR","03677","BK1619","LU1366334578.USD","01448","03396","SG9999002950.SGD","LU1508157978.USD","02552","LU1939255532.USD","BK1141","BK1616","BK1617","BK1512","SG9999014674.SGD","BK1607","BK1128","LU0370786039.SGD","BK1143","LU0228659784.USD","BK1111","LU0561508036.HKD","06633","09992","BK1179","LU0594300419.USD","BK1531","SG9999000459.SGD","BK1161","02598","LU0509642566.USD","LU2488822045.USD","LU2357125470.USD","LU0605514214.HKD","02451","03738","BK1541","LU0417516902.SGD","LU0289739343.SGD","LU0173614495.USD","02400","LU0261950983.USD","LU0541501648.USD","LU0307460666.USD","01681","LU1152091754.HKD","LU0359202008.SGD","01177","06608","BK1592","LU0310800965.SGD","02256","09959","LU0348825331.USD","LU0865486749.SGD","06988","00999","LU0175139822.USD","LU0455707207.USD","LU0143863784.USD","IE00BD6J9T35.USD","LU0823426480.USD","LU1969619763.USD","LU0143863198.USD","LU0823414478.USD","02587","LU0823437842.USD","LU1328277881.USD","LU0449515922.USD","01651","LU0084288322.USD","03998","LU2449936058.SGD","BK1163","06069","SG9999015986.USD","IE00B8L5B284.USD","LU0128525689.USD","BK1189","BK1588","09880","03650","LU1102505762.USD","LU0823397285.USD","LU2106854487.HKD","BK1110","02511","09636","LU2097828474.EUR","02567","BK1502","LNNGY","LU0823414551.USD","LU2097828714.EUR","SG9999004311.SGD","HK0000165453.HKD","SG9999006514.SGD","02013","00017","LU1961090484.USD","LNVGY","LU0791591158.USD","BK1190","IE0008368742.USD","LU0737861772.HKD","BK1117","LU0540923850.HKD","01333","BK1553","LU0348805143.USD","02858","06090","06168","LU1251922891.USD"],"gpt_icon":1},{"id":"1140534886","title":"China Medical System (00867) Reports Unchanged Share Capital and Issued Shares for November 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=1140534886","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1140534886?lang=en_us&edition=fundamental","pubTime":"2025-12-01 17:26","pubTimestamp":1764581196,"startTime":"0","endTime":"0","summary":"China Medical System Holdings Limited (stock code: 00867) released its monthly return on movements in securities for November 2025. The authorized share capital remained at USD 100,000,000, with no...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00867"],"gpt_icon":0},{"id":"2585178097","title":"China Medical System Holdings' (HKG:867) one-year total shareholder returns outpace the underlying earnings growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2585178097","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585178097?lang=en_us&edition=fundamental","pubTime":"2025-11-22 07:23","pubTimestamp":1763767411,"startTime":"0","endTime":"0","summary":"If you want to compound wealth in the stock market, you can do so by buying an index fund. But you can significantly...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-867/china-medical-system-holdings-shares/news/china-medical-system-holdings-hkg867-one-year-total-sharehol","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-867/china-medical-system-holdings-shares/news/china-medical-system-holdings-hkg867-one-year-total-sharehol","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["00867"],"gpt_icon":0},{"id":"1117424956","title":"Riding the Hong Kong Stock Rally: Bull Market Dawns in the East 2026 – 10th Zhitong Finance Capital Markets Annual Conference Invites You to a Capital Feast","url":"https://stock-news.laohu8.com/highlight/detail?id=1117424956","media":"Stock News","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117424956?lang=en_us&edition=fundamental","pubTime":"2025-11-18 08:56","pubTimestamp":1763427395,"startTime":"0","endTime":"0","summary":"As the fourth technological revolution sweeps across the globe, with AI and large model technologies reaching critical breakthroughs, capital engines are driving the revaluation of Chinese assets at...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00826","01681","BK1552","BK1609","LU2778985437.USD","BK1137","LU0348766576.USD","02380","BK1104","LU0348825331.USD","BK1591","BK1186","SG9999004220.SGD","01167","00604","02256","02886","09878","LU1634259391.SGD","01969","BK1225","02171","BK1518","BK1142","BK1596","BK1595","HK0000252152.HKD","HK0000500386.USD","00363","02157","BK1202","IE00BVYPNQ40.USD","01907","BK1506","BK1524","BK1585","BK1500","BK1575","BK1574","BK1578","02858","BK1556","LU2488822045.USD","BK1216","BK1188","BK1124","IE00BPRC5H50.USD","BK1228","02279","BK1613","LU1497733631.SGD","BK1147","BK1139","06682","02551","LU1497733557.USD","BK1579","BK1140","BK1161","BK1229","BK1582","06996","BK1583","02096","BK1114","LU1634259557.SGD","SG9999001069.SGD","01783","06609","BK1125","BK1608","00699","BK1531","BK1100","SG9999002950.SGD","BK1193","SG9999015986.USD","03145","02268","03315","01651","BK1150","IE00BVYPNP33.GBP","IE00B543WZ88.USD","LU1522347837.USD","IE00BYV24P56.USD","BK1224","02488","BK1587","00305","02453","01164","BK1163","BK1116","02509","IE00BGHQDM52.EUR","BK1539","LU1497734951.SGD","SG9999015952.SGD","BK1141","02142","09919","BK1109","02105","BK1209","02420","01762","BK1527","SG9999015945.SGD","LU2460026573.USD","01809","06660","06919","LU1808992512.USD","00302","03658","BK1618","BK1178","BK1516","BK1095","BK1592","BK1183","09911","02431","02627","06069","BK1586","02177","01333","02561","09996","01228","01318","00861","02567","06633","BK1221","SG9999015978.USD","BK1207","SG9999014674.SGD","00552","BK1191","BK1148","00855","BK1110","02587","09860","BK1171","BK1530","BK1542","BK1175","02411","BK1155","IE00BMCWC346.EUR","LU2476274308.USD","BK1619","BK1521","00867","00290","BK1131","BK1144","02616","BK1230","BK1594","BK1577","IE00B5MMRT66.SGD","06100","SG9999003461.SGD","BK1606","BK1555","00003","09678","LU0348767384.USD","BK1219","LU2476274720.SGD","02167","03738","00382","BK1529","BK1132","09959","06677","00196","01773","02670","06090","BK1593","BK1258","BK1194","HK0000252160.HKD","02533","LU0417516902.SGD","02511","06608"],"gpt_icon":0},{"id":"2580780165","title":"Exclusive Novartis Ophthalmology Deal Might Change The Case For Investing In China Medical System Holdings (SEHK:867)","url":"https://stock-news.laohu8.com/highlight/detail?id=2580780165","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580780165?lang=en_us&edition=fundamental","pubTime":"2025-11-04 15:17","pubTimestamp":1762240658,"startTime":"0","endTime":"0","summary":"On October 27, 2025, China Medical System Holdings announced that its subsidiary CMS Vision International Management Limited had entered into an exclusive five-year distribution agreement with Novartis Pharma Services AG to import, distribute, sell, and promote Lucentis and Beovu injections in mainland China.\nThis collaboration expands CMS Vision's ophthalmology portfolio with two key, internationally recognized treatments, strengthening its market presence and offering broader therapeutic...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-867/china-medical-system-holdings-shares/news/exclusive-novartis-ophthalmology-deal-might-change-the-case","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-867/china-medical-system-holdings-shares/news/exclusive-novartis-ophthalmology-deal-might-change-the-case","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IE00BVYPNQ40.USD","00867","SG9999015978.USD","SG9999015952.SGD","SG9999015986.USD","BK1191","SG9999015945.SGD","IE00BMCWC346.EUR","IE00BYV24P56.USD","IE00BGHQDM52.EUR","SG9999004220.SGD","BK1593","LU2488822045.USD","IE00BVYPNP33.GBP"],"gpt_icon":0},{"id":"2580446358","title":"Are China Medical System Holdings Limited's (HKG:867) Mixed Financials Driving The Negative Sentiment?","url":"https://stock-news.laohu8.com/highlight/detail?id=2580446358","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580446358?lang=en_us&edition=fundamental","pubTime":"2025-11-01 06:40","pubTimestamp":1761950429,"startTime":"0","endTime":"0","summary":"It is hard to get excited after looking at China Medical System Holdings' (HKG:867) recent performance, when its stock...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-867/china-medical-system-holdings-shares/news/are-china-medical-system-holdings-limiteds-hkg867-mixed-fina","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-867/china-medical-system-holdings-shares/news/are-china-medical-system-holdings-limiteds-hkg867-mixed-fina","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["SG9999004220.SGD","BK1191","00867","IE00BVYPNP33.GBP","BK1593","SG9999015978.USD","IE00BMCWC346.EUR","IE00BVYPNQ40.USD","LU2488822045.USD","SG9999015945.SGD","SG9999015952.SGD","IE00BGHQDM52.EUR","IE00BYV24P56.USD","SG9999015986.USD"],"gpt_icon":0},{"id":"1153654174","title":"China Medical System (00867) Issues Monthly Return for October 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=1153654174","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153654174?lang=en_us&edition=fundamental","pubTime":"2025-10-31 20:25","pubTimestamp":1761913538,"startTime":"0","endTime":"0","summary":"China Medical System Holdings Limited (stock code: 00867) published its monthly return for equity issuers for the period ending 31 October 2025. The authorized share capital remained at...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00867"],"gpt_icon":0},{"id":"1146671574","title":"CMS (00867): China's NMPA Accepts Marketing Application for Long-Acting Anti-IL-4Rα Monoclonal Antibody for Atopic Dermatitis","url":"https://stock-news.laohu8.com/highlight/detail?id=1146671574","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146671574?lang=en_us&edition=fundamental","pubTime":"2025-10-30 18:56","pubTimestamp":1761821800,"startTime":"0","endTime":"0","summary":"CMS (00867) announced that the marketing authorization application (MAA) for its innovative Class 1 new drug, anti-IL-4Rα humanized monoclonal antibody injection MG-K10 (generic name: Komeqimab...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00867","SG9999004220.SGD","SG9999015945.SGD","IE00BVYPNP33.GBP","SG9999015978.USD","BK1593","LU2488822045.USD","IE00BVYPNQ40.USD","BK1191","SG9999015952.SGD","SG9999015986.USD","IE00BGHQDM52.EUR","IE00BYV24P56.USD","IE00BMCWC346.EUR"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cms.net.cn","stockEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":0.0418},{"period":"3month","weight":0.0277},{"period":"6month","weight":0.0391},{"period":"1year","weight":0.9494},{"period":"ytd","weight":0.0636}],"compareEarnings":[{"period":"1week","weight":-0.0154},{"period":"1month","weight":0.0304},{"period":"3month","weight":0.0238},{"period":"6month","weight":0.0471},{"period":"1year","weight":0.3222},{"period":"ytd","weight":0.0372}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"China Medical System Holdings Ltd is an investment holding company principally engaged in the production of medicines, as well as marketing, promotion and sales of drugs. The Company's products include Plendil, Ursofalk, Augentropfen Stulln Mono Eye Drops, Hirudoid, Atopic Piel Series and Vmonalisa, among others. Its major marketed products cover the cardio-cerebrovascular, gastroenterology, ophthalmology, dermatology and medical aesthetic fields. The Company distributes its products within domestic market and to overseas markets.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.009482},{"month":2,"riseRate":0.571429,"avgChangeRate":0.034237},{"month":3,"riseRate":0.466667,"avgChangeRate":-0.002353},{"month":4,"riseRate":0.533333,"avgChangeRate":0.029521},{"month":5,"riseRate":0.466667,"avgChangeRate":0.01146},{"month":6,"riseRate":0.666667,"avgChangeRate":0.005887},{"month":7,"riseRate":0.533333,"avgChangeRate":-0.008683},{"month":8,"riseRate":0.4,"avgChangeRate":0.021846},{"month":9,"riseRate":0.466667,"avgChangeRate":0.00566},{"month":10,"riseRate":0.5,"avgChangeRate":0.008421},{"month":11,"riseRate":0.5625,"avgChangeRate":0.054281},{"month":12,"riseRate":0.5625,"avgChangeRate":0.03433}],"exchange":"SEHK","name":"CMS","nameEN":"CMS"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CMS(00867),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest CMS(00867) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"CMS,00867,CMS股票,CMS股票老虎,CMS股票老虎国际,CMS行情,CMS股票行情,CMS股价,CMS股市,CMS股票价格,CMS股票交易,CMS股票购买,CMS股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CMS(00867),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest CMS(00867) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}